GE HealthCare will also be showcasing the recently CE marked and U.S. FDA cleared ECG-less Cardiac CT solution, which can acquire cardiac images without the aid of the patients’ ECG signal/trace. This technology is applied in examinations where it is clinically advantageous to prioritize patient access or speed when the ECG signal is unavailable. ECG-less Cardiac CT scanning is exclusively available on and further enhances the capabilities of the company’s Revolution Apex Elite, which already boasts a 160mm detector configuration and the ability to achieve one-beat, high definition, motion-free coronary images at any heart rate. This system is available as a part of GE HealthCare’s broader Revolution Apex platform, a world class scalable CT solution that offers modern computed tomography (CT) technology to provide versatile clinical solutions for even the most challenging patients.
The advanced technology is further enhanced with Effortless Workflow, which intelligently automates the CT workflow from pre-scan protocoling to post-scan processing, using AI-based features to help transform the entire CT experience and provide optimal efficiency, accuracy, clarity and consistency. This enables technologists to personalize scans automatically and accurately for each patient with significantly less effort. The results are high quality CT images acquired more quickly and efficiently: 56% reduction in positioning time3; 66% reduction in total exam clicks4; and 21% reduction in total exam time5.
“Providing rapid, flexible and at the point of care cardiac diagnostics is critical in terms of patient outcomes – however, timely care can be extremely difficult to deliver, particularly within already-stretched healthcare systems where clinicians face time and resource constraints,” said Eigil Samset, general manager, Cardiology Solutions, GE HealthCare. “Through our innovative cardiology solutions and by leveraging the power of AI, we aim to address these challenges and help clinicians understand the complete story of their patients’ hearts as quickly as possible. I am thrilled that this suite of integrated cardiac care solutions is now accessible to more providers so that they are able to deliver efficient and timely patient care when and where it is needed most.”
Building on the recent CE marks, these innovative cardiology solutions will be on display at GE HealthCare Booth # F400 South in a fully functional cardiac catheterization laboratory at ESC Congress 2024. The lab will showcase the company’s latest image guided platform Allia™ IGS 5 Pulse, designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology, as well as feature INTERACT Touch with AVVIGO+™ Multi-Modality Guidance System from Boston Scientific6 - the first third party application available with this technology.
